Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 938 results for "glaxo"

Are Royal Dutch Shell Plc, BT Group plc And GlaxoSmithKline plc Brilliant Bargains Or Value Traps?
Yahoo! UK and Ireland

Are Royal Dutch Shell Plc, BT Group plc And GlaxoSmithKline pl...

Today I am looking at the investment prospects of three cut-price FTSE candidates. Royal Dutch Shell Shares in Royal Dutch Shell (LSE: RDSB) have rattled steadily lower since last summer due to fears over the future of the crude price. Indeed, ... Yahoo! UK and Ireland, 14 hours ago

615 images for glaxo

American Banking News - Forex, 10 hours ago
Octafinance, 10 hours ago
Octafinance, 2 days ago
Octafinance, 4 days ago
American Banking News - Forex, 1 week ago
Octafinance, 1 week ago
Premier Construction, 21 hours ago
Yahoo! Finance UK and Ireland, 14 hours ago
Pharmaceutical Technology, 5 days ago
Pharmafile, 2 days ago
American Banking News - Forex

GlaxoSmithKline plc Stock Rating Reaffirmed by Natixis (GSK)

GlaxoSmithKline plc (LON:GSK)s stock had its neutral rating reaffirmed by equities researchers at Natixis in a research report issued to clients and investors on Wednesday, ARN reports. They presently have a GBX 1,470 ($22.33) target price on the ...
 American Banking News - Forex10 hours ago Natixis Reconfirms GBX 1470 Target Price On GlaxoSmithKline (LON:GSK), Reconfirms Neutral Rating  Octafinance11 hours ago GlaxoSmithKline PLC (LON:GSK) Stock Hold Rating Reaffirmed at Kepler Cheuvreux; The Target is Set to GBX 1540.00  Octafinance2 days ago GlaxoSmithKline plc Earns Neutral Rating from BNP Paribas (GSK)  American Banking News - Forex5 days ago
Business Standard

GSK Pharma completes acquisition of Novartis vaccines business

GlaxoSmithKline Pharmaceuticals has announced completion of its transaction with Novartis India today where GSK India acquires Novartis' vaccines business and divests its marketed oncology portfolio to Novartis India. This follows a global deal between parent ...
 Business Standard1 week ago GSK Pharma completes deal with Novartis Healthcare  Business Standard1 week ago GlaxoSmithKline Pharmaceuticals Completes Transaction with Novartis  Money Control1 week ago GSK launches flagship cardiology drug Benitec in Sri Lanka  DailyFT1 week ago
Yahoo! Finance UK and Ireland

Should You Buy BP plc And GlaxoSmithKline plc For Your Income Portfolio?

In years gone by, BP (LSE: BP) and GlaxoSmithKline (LSE: GSK) would have been automatic inclusions to income-seeking portfolios. The two companies are FTSE heavyweights, the 5th and 6th biggest companies listed on the London Stock Exchange ...
 Yahoo! Finance UK and Ireland2 days ago
Yahoo! Finance UK and Ireland

4 Of The Best Income Stocks Around: GlaxoSmithKline plc, Standard Life Plc, SSE PLC And Centrica plc

Standard Life (LSE: SL) has transformed itself into an income champion over the past five years. The company's shift to a fee-based business model has led to a tripling of cash flow generated from operations since 2010. Assets under management have ...
 Yahoo! Finance UK and Ireland1 week ago
Yahoo! UK and Ireland

Neil Woodford Still Believes in AstraZeneca plc And GlaxoSmithKline plc. Should you?

When star dividend investor Neil Woodford announced the top 10 holdings in his new fund CF Woodford Equity Income last year, two old favourites stoodright at the top of the list. Woodford has been a long-term admirer of pharmaceutical giants ...
 Yahoo! UK and Ireland1 week ago
Reuters India

GSK may get EU green light for new biotech asthma drug this week

LONDON GlaxoSmithKline may get a green light from European regulators as early as this week for a new biotech medicine to treat severe asthma, boosting prospects for its struggling respiratory business. A recommendation from the European Medicines ...
 Reuters India2 weeks ago GlaxoSmithKline may get EU green light for new biotech asthma drug this week  Economic Times2 weeks ago Novartis melanoma drug combination wins EU green light  Reuters2 months ago
Yahoo! Finance UK and Ireland

3 Of The Best Health Care Stocks: GlaxoSmithKline plc, Smith & Nephew plc And Advanced Medical Solutions Group plc

The health care sector is a hugely appealing place to invest for the long term. That's because it offers excellent growth prospects, with demand for drugs and treatments likely to increase as the world's population rises and the emerging world ...
 Yahoo! Finance UK and Ireland2 weeks ago Is Patience Really A Virtue For Investors In Aviva plc, GlaxoSmithKline plc And Unilever plc?  Yahoo! Finance UK and Ireland3 weeks ago GlaxoSmithKline plc (ADR) (GSK) Stock Update: Mixed Signals For Investors  Bidness Etc3 weeks ago Biotech Battle: Should You Buy GlaxoSmithKline plc, Shire PLC Or Hikma Pharmaceuticals Plc?  Yahoo! Finance UK and Ireland3 weeks ago
BioPharma Dive

After bad news on Breo, Glaxo's monthly asthma drug wins an EU rec

Dive Brief: GlaxoSmithKline'sNucala (mepolizumab) is an injectable IL-5 monoclonal antibody designed to treat severe asthma in patients who are non-responsive to high-dose inhaled corticosteroids. The Committee for Medicinal Products for Human ...
 BioPharma Dive1 week ago EU regulator backs approval for GSK injectable asthma drug  Reuters1 week ago European regulator recommends approving GSK injectable asthma drug  The World 247.com1 week ago Report: Glaxo withheld critical data on antidepressant Seroxat  BioPharma Dive2 weeks ago
Pharmaceutical Manufacturing Magazine

GSK Lung Drug Disappoints in Trials GlaxoSmithKline's inhaled medicine Breo failed to prolong life in patients…

GlaxoSmithKline's inhaled medicine Breo failed to prolong life in patients with chronic respiratory disease in a large clinical trial. The study tested the drug on 16,485 chronic obstructive pulmonary disease (COPD) patients with moderate airflow ...
 Pharmaceutical Manufacturing Magazine2 weeks ago Drug by GlaxoSmithKline Fails To Prolong Life In Patients With Chronic Respiratory Disease  MedIndia4 weeks ago Study finds key Glaxo-Theravance lung drug didn't extend lives  CTV News4 weeks ago Glaxo takes a big blow as 'son of Advair' fails to extend COPD patients' lives  BioPharma Dive4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less